Category - Pharma Industry News
NAFDAC Warns Against Use of Weight Loss Pill
Already on a roll in oncology, Astellas hunts for big wins in other areas
Drug price negotiations: 5 key dates to watch
Tactics for growing your walled garden presence
NAPharm Honours Afe Babalola, Inducts 20 Fellows
Stakeholders Proffer Technology as Panacea to Drug Distribution Challenge
January 20 2023 – Innovative trial design may have cost Lilly’s accelerated Alzheimer’s approval
FDA rejects accelerated approval for Eli Lilly’s Alzheimer’s drug, donanemab